Further Information
FCRL1, Fc receptor-like 1, CD307a, FCRH1, IFGP1, IRTA5, Fc receptor-like protein 1, IFGP family protein 1, fc receptor homolog 1, fcR-like protein 1, hIFGP1, immune receptor translocation-associated protein 5, immunoglobulin superfamily Fc receptor, gp42
Peptide ELISA: antibody detection limit dilution 1:64000.Western Blot:Approx 45 + 40kDa bands observed in Human Heart lysates and 38kDa in Human Liver lysates (calculated MW of 46.9kDa according to NP_443170.1 and of 40.4kDa according to NP_001152869.1). Recommended concentration: 0.3-1ug/ml.
- Du X, Nagata S, Ise T, Stetler-Stevenson M, Pastan I.FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.
Supplied at 0.5 mg/ml in Tris saline, 0.02% sodium azide, pH7.3 with 0.5% bovine serum albumin.
Aliquot and store at -20?C. Minimize freezing and thawing.
500 ug/mL
Unconjugated
Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. Optimal dilutions/concentrations should be determined by the end user. The information provided is a guideline for product use. This product is for research use only.
The immunogen for this antibody is: C-TAEYEIPSVRESD
115350
Fc receptor-like 1
FCRL1
Homo sapiens
Liquid
PREDICTED MOLECULAR WEIGHT:
Approx 45 + 40kDa
NP_443170.1, NP_001152869.1, NP_001152870.1
16418419
Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
Cancer,Signal Transduction,Cancer Signal Transduction Membrane Membrane
This antibody is expected to recognize all reported isoforms (NP_443170.1; NP_001152869.1; NP_001152870.1).
Q96LA6